Free tool
FAERS Monitor: Iosat
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018664 or its brand name (Iosat, Potassium Iodide). Reports on generic versions are filed under their own applications.
Reports
1,413
Serious
1,272
90% of reports
Hospitalization
498
Death reported
385
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea276
- haemorrhagic stroke257
- sepsis257
- dyspnoea256
- fatigue250
- fall247
- headache243
- tachycardia242
- cardio-respiratory arrest241
- insomnia240
- dizziness239
- cough238
- nausea236
- altered state of consciousness235
- arthralgia230
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 9 |
| 2007 | 14 |
| 2008 | 14 |
| 2009 | 16 |
| 2010 | 13 |
| 2011 | 14 |
| 2012 | 12 |
| 2013 | 26 |
| 2014 | 28 |
| 2015 | 38 |
| 2016 | 48 |
| 2017 | 50 |
| 2018 | 62 |
| 2019 | 76 |
| 2020 | 104 |
| 2021 | 91 |
| 2022 | 186 |
| 2023 | 162 |
| 2024 | 263 |
| 2025 | 133 |
| 2026 | 46 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,746 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| haemorrhagic strokeSignal | 257 | 506.4 | 452.3 | 124,920 |
| altered state of consciousnessSignal | 235 | 163.3 | 145.2 | 37,364 |
| cardio-respiratory arrestSignal | 241 | 86.3 | 76.9 | 20,154 |
| tachycardiaSignal | 242 | 40.7 | 36.2 | 9,335 |
| sepsisSignal | 257 | 34.4 | 30.8 | 8,319 |
| insomniaSignal | 240 | 13.4 | 12.0 | 2,780 |
| coughSignal | 238 | 12.6 | 11.3 | 2,572 |
| fallSignal | 247 | 11.1 | 9.9 | 2,283 |
| arthralgiaSignal | 230 | 8.2 | 7.3 | 1,484 |
| dizzinessSignal | 239 | 7.1 | 6.4 | 1,285 |
| dyspnoeaSignal | 256 | 6.7 | 6.0 | 1,278 |
| diarrhoeaSignal | 276 | 6.4 | 5.7 | 1,282 |
| headacheSignal | 243 | 5.8 | 5.1 | 983 |
| fatigueSignal | 250 | 4.8 | 4.3 | 772 |
| nauseaSignal | 236 | 4.4 | 4.0 | 650 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.